EUVIMEDEUVIMED entdecken
Crossref

How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease

Shin Yeong Kang, Yu Ho Lee, Su Jin Jeong, Jin Sug Kim, Kyung Hwan Jeong, Hyeon Seok Hwang

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfad214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Shin Yeong Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Cardiovascular Diseases, Disease Progression. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity and metabolic syndrome (MetS) are prevalent among chronic kidney disease (CKD) patients. However, it is unclear whether obesity without MetS is associated with a higher risk of adverse clinical outcomes in CKD patients.

Methods

We searched the National Health Insurance Service database of Korea for patients who underwent national health screenings in 2009–11 and identified 59 725 CKD patients. Obesity was defined as a body mass index ≥25 kg/m2. MetS was defined as the presence of three or more metabolic risks.

Results

The cumulative event rate of cardiovascular (CV) events, progression to end-stage kidney disease (ESKD) and all-cause mortality was the lowest among obese patients without MetS (all P < .001). In multivariable analysis, obese (versus non-obese) patients without MetS were not at increased risks of CV events [adjusted hazard ratio (HR) 1.02 (95% confidence interval 0.94–1.11)] or progression to ESKD [0.92 (0.77–1.09)]. Their risk of all-cause mortality was significantly decreased [0.82 (0.75–0.90)]. These findings were consistently observed in overweight, obese and morbidly obese patients without MetS. Moreover, despite a linear increase in HR for each additional metabolic abnormality in both obese and non-obese patients, the slope of HR increase for CV events was significantly slower in obese patients (P for interaction = .038).

Conclusions

Obesity without MetS did not increase the risk of CV complications or progression to ESKD. The healthy effect of obesity on all-cause mortality risk and its weakening effect on the association between metabolic hazards and CV risk should be considered in CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeObesityCardiovascular DiseasesDisease ProgressionRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedRisk FactorsRepublic of KoreaCause of DeathAgedPrognosisSurvival RateFollow-Up StudiesKidney Failure, ChronicAdultGlomerular Filtration Rate

Stichwörter der Autor:innen

chronic kidney diseasemetabolic syndromeobesity

Autor:innen und Institutionen

  • Department of Internal Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.
  • Statistics Support Part, Medical Science Research Institute, Kyung Hee University, Seoul, South Korea.
  • Division of Nephrology, Department of Internal Medicine, College of Medicine, Kyung Hee University, Kyung Hee University Hospital, Seoul, South Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kang, S. Y., Lee, Y. H., Jeong, S. J., Kim, J. S., Jeong, K. H., & Hwang, H. S. (2024). How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad214

Vancouver

Kang SY, Lee YH, Jeong SJ, Kim JS, Jeong KH, Hwang HS. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad214

BibTeX
@article{Kang2024,
  author = {Kang, Shin Yeong and Lee, Yu Ho and Jeong, Su Jin and Kim, Jin Sug and Jeong, Kyung Hwan and Hwang, Hyeon Seok},
  title = {How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad214}
}
Kostenlos starten →